Mediastinal Fibrosarcoma in a Dog-Case Report
Alysha M McGrath1, Sarah A Salyer1, Amanda Seelmann2
1Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH, United States.
This report documents the first known instance of a fibrosarcoma originating in the mediastinum of a dog. The patient, an eight-year-old mixed breed, presented with breathing difficulties and lethargy. Imaging confirmed a large mass, which was surgically removed alongside part of the lung. Although the tumor recurred months later, the case highlights the importance of including this rare cancer in diagnostic considerations for chest masses.
Area of Science:
- Veterinary oncology and mediastinal fibrosarcoma diagnostics
- Small animal thoracic surgery and clinical pathology
Background:
No prior work had resolved the clinical presentation of primary mediastinal tumors arising from fibrous connective tissue in canine patients. That uncertainty drove a need for detailed documentation of rare thoracic malignancies. It was already known that mediastinal masses often stem from thymic or lymphatic origins. Prior research has shown that fibrosarcomas typically occur in cutaneous or subcutaneous locations. This gap motivated the current report to characterize a unique case of mediastinal involvement. Clinicians frequently encounter diagnostic challenges when evaluating cranial thoracic masses in aging animals. The absence of established literature regarding this specific tumor location complicates prognostic assessments. This report addresses the lack of documented evidence for such rare presentations in veterinary medicine.
Purpose Of The Study:
The aim of this report is to document the first published case of mediastinal fibrosarcoma in a dog. This study addresses the diagnostic and therapeutic challenges associated with this rare thoracic malignancy. The authors seek to provide clinical data on a presentation that has not been previously described in veterinary literature. By detailing the patient's history, the report highlights the necessity of considering diverse differential diagnoses for cranial mediastinal masses. The motivation for this work stems from the need to improve awareness of unusual tumor locations in canine patients. This case serves as a reference for clinicians encountering similar thoracic pathologies. The researchers intend to share the surgical and adjuvant treatment outcomes observed in this specific patient. These details contribute to the growing body of knowledge regarding rare canine neoplasms.
Main Methods:
Review Approach involved a comprehensive analysis of a single canine clinical case. The team performed a thoracic focused assessment with sonography for trauma to evaluate pleural effusion. Radiographic imaging served as the initial screening tool for identifying the cranial mediastinal mass. Computed tomography provided high-resolution cross-sectional views of the thoracic cavity. Surgical exploration allowed for direct visualization and physical removal of the neoplastic tissue. The surgeons employed a vessel sealant device to facilitate the en-bloc resection process. A partial lung lobectomy was conducted to address the adhesion between the tumor and the lung. Histopathological examination of the excised mass and regional lymph nodes confirmed the final diagnosis.
Main Results:
Key Findings From the Literature indicate that this is the first documented instance of this tumor type in the canine mediastinum. The patient survived for a total of 223 days after the initial diagnosis. Recurrence of the disease was identified 161 days following the start of the diagnostic process. The mass was located within the right ventral aspect of the cranial mediastinum. Surgical removal involved an en-bloc resection and a partial lung lobectomy. Histopathology revealed the presence of reactive mesothelial cells within the sternal lymph node. Systemic chemotherapy was administered as an adjuvant treatment following the surgical procedure. Radiation therapy was subsequently initiated after the tumor returned in the thoracic cavity.
Conclusions:
The authors propose that primary mediastinal fibrosarcoma represents a rare but plausible cause of thoracic pathology in dogs. This synthesis suggests that clinicians should include this malignancy in differential diagnoses for cranial mediastinal masses. The report highlights that surgical resection remains a viable approach for managing these aggressive tumors. Authors note that recurrence remains a significant risk despite successful initial removal and subsequent chemotherapy. The findings imply that long-term monitoring is necessary for patients diagnosed with this specific neoplasm. The team observes that radiation therapy may be utilized following the return of the disease. This review of the case underscores the complexity of treating mediastinal tumors in canine patients. These implications provide a foundation for future clinical awareness regarding rare thoracic fibrous growths.
Frequently Asked Questions
The researchers identified a cranial mediastinal mass through computed tomography and surgical exploration. Histopathology confirmed the diagnosis as fibrosarcoma, with reactive mesothelial cells found in the sternal lymph node, distinguishing it from common thymic or lymphatic tumors.
The clinical team utilized a vessel sealant device to perform an en-bloc resection of the mass. This procedure necessitated a partial lung lobectomy due to an adhesion between the tumor and the right cranial lung lobe.
The authors state that the right ventral aspect of the cranial mediastinum was the precise location. This anatomical site is necessary to distinguish the tumor from other thoracic structures during imaging and surgical planning.
Computed tomography provided the detailed spatial information needed to localize the mass. This imaging modality allowed the team to visualize the relationship between the tumor and the surrounding lung tissue before surgical intervention.
The patient survived for 223 days following the initial diagnosis. Recurrence of the mass was observed 161 days after the diagnosis, which prompted the initiation of radiation therapy as a secondary treatment strategy.
The researchers propose that this condition should be included in differential diagnoses for cranial mediastinal masses. They suggest that while rare, this tumor type is a potential cause of thoracic pathology in dogs.
